Biochain
BioChain Institute Inc. is a privately held life sciences research products and services company founded in 1994, supplying biospecimens, nucleic acid extraction kits, automated AnaPrep instruments, reference standards, and spatial multiomics services to pharmaceutical, biotechnology, academic, and molecular diagnostics customers globally.
- Company typePrivate
- Founded1994
- HeadquartersNewark, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biochain does
BioChain Institute Inc. is a privately held life sciences research products and services company founded in 1994 and headquartered at 39600 Eureka Drive, Newark, California. The company supplies human biospecimens (FFPE tissue, frozen tissue, DNA, RNA, protein, matched pair tumor/normal samples), nucleic acid extraction kits, automated sample preparation instruments, reference and control standards, and spatial multiomics services to pharmaceutical, biotechnology, academic, and molecular diagnostics customers. BioChain claims to serve the top 500 global pharmaceutical and biotechnology firms and academic leaders and reports that over 3,000 peer-reviewed publications reference its products, signaling deep integration into established research workflows.
The company's core technology centers on proprietary xTractPure magnetic bead-based extraction chemistry, deployed through the AnaPrep 12 Dx (CFR 21 Part 11 compliant for clinical diagnostics) and AnaPrep 48 automated nucleic acid extraction instruments, with FFPE-specific kits that address cross-linking and degradation in archived specimens. BioChain operates certified spatial biology services through partnerships with 10x Genomics (Visium HD whole-transcriptome at 2µm resolution and Xenium Prime 5K single-cell imaging) and NanoString (GeoMx DSP), providing end-to-end workflows from biospecimen sourcing through tissue characterization and multiomic profiling. ISO 9001:2015 certification for OEM manufacturing, ISO certification plus IRB approval for biospecimen operations, and FDA-approved tissue arrays constitute the regulatory foundation underpinning clinical trial and diagnostic customer use cases.
BioChain monetizes through catalog biospecimen and reagent sales at published unit prices, instrument sales ($34,300 for AnaPrep 48), consumable pull-through, and quote-based custom services including spatial multiomics, histology, biospecimen procurement, targeted gene expression profiling, and OEM manufacturing. Distribution is direct via biochain.com for US customers, supplemented by an international distributor network. Named customers include Regeneron, GSK, Roche, Teva, Thermo Fisher Scientific, Harvard University, NIH, and Science Exchange. The company is led by co-founder Zhi Yang and Chief Business Officer Bingfang Huan, with operations spanning the United States and partner-served international markets.
Biochain firmographics
Firmographics- Name
- Biochain
- Legal name
- BioChain Institute Inc.
- Website
- https://biochain.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- BioChain Institute Inc. is a privately held life sciences research products and services company founded in 1994, supplying biospecimens, nucleic acid extraction kits, automated AnaPrep instruments, reference standards, and spatial multiomics services to pharmaceutical, biotechnology, academic, and molecular diagnostics customers globally.
- Ownership category
- akta.pro rank
Biochain industry classification
Industry- Product category
- Life Science Research Products
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)
- SIC
- Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Sample Collection, Stabilization & Pre-Analytics (biobanking, transport media, extraction kits) (HLAAALAM)
- akta.pro secondary industries
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Sample / Biorepository & Biobank Informatics (Chain-of-Custody) (HLAGAJAH)
Keywords
Where Biochain is headquartered
LocationHeadquarters
- HQ city
- Newark
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Biochain business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Biospecimen Sales: Sale of human biospecimens including FFPE tissue, frozen tissue, DNA, RNA, protein, and matched pair samples (tumor and adjacent normal) for research applications. Products sold via catalog and custom procurement.
- Automated Instruments: Sale of AnaPrep 12 Dx and AnaPrep 48 automated nucleic acid extraction instruments, priced at $34,300 for the AnaPrep 48 instrument. Consumables and reagents for these instruments are sold separately as recurring revenue.
- Extraction and Purification Kits: Sale of xTractPure extraction kits for DNA, RNA, and protein from various sample types. Includes AnaPrep reagent kits sold in pack sizes (e.g., 48 extractions). Kit prices range from $380 to $880 depending on the kit type.
- Custom Services: Fee-for-service including spatial multiomics services (10x Visium, Xenium, NanoString GeoMx), biospecimen procurement, custom extraction and purification, histology services, targeted gene expression profiling, and OEM manufacturing (ISO 9001:2015 certified).
- Reference and Control Standards: Sale of reference tissues, reference DNA/RNA/protein, characterized tissues, FDA arrays, HCR verified tissues, and plasma reference materials for use as controls in molecular diagnostic and research assays.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Catalog biospecimen products with published unit prices |
| Unit Pricing | One time/ perpetual license | AnaPrep automated instruments |
| Unit Pricing | Pay-as-you-go | xTractPure extraction kit products |
| Unit Pricing | Pay-as-you-go | AnaPrep reagent kits for automated extraction |
| Other | Multi-year contract | Custom services and spatial biology services |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Biochain product offering
Product offeringCore offering
BioChain supplies human biospecimens (FFPE and frozen tissue, DNA, RNA, protein, matched pair samples), automated nucleic acid extraction instruments (AnaPrep 12 Dx and AnaPrep 48), magnetic bead-based extraction kits (xTractPure), reference and control standards (FDA-approved tissue arrays, characterized tissues), and fee-for-service spatial multiomics and histology services to pharmaceutical, biotechnology, academic, and government research customers.
Differentiator
Problem solved
Functional benefit
Products and services
- Human Biospecimens (FFPE Tissue, Frozen Tissue, DNA, RNA, Protein, Matched Pair Samples) Catalogue of high-quality, characterized human biospecimens including FFPE and frozen tissue sections, isolated DNA, RNA, and protein, and matched tumor/normal paired samples, sourced under ISO and IRB approved procurement for genomics, NGS, qPCR, and spatial biology research.
- AnaPrep Automated Sample Preparation Systems (AnaPrep 12 Dx and AnaPrep 48) Benchtop automated nucleic acid extraction instruments using magnetic bead technology with pre-programmed protocols; the AnaPrep 48 processes up to 48 samples and is positioned as an open system compatible with third-party magnetic bead kits, while the AnaPrep 12 Dx adds traceability for clinical diagnostic use.
- xTractPure Extraction and Purification Kits Magnetic bead-based extraction kits for DNA, RNA, and protein from diverse sample types, including dedicated FFPE DNA, FFPE DR (combined RNA/DNA), biofluid DNA, blood RNA, cell and tissue nucleic acid, and viral nucleic acid kits, suitable for use on the AnaPrep 48 and other open magnetic bead systems.
- Liquid Biopsy Solutions (cfPure cell-free nucleic acid kits and mutational quantification control plasma) Cell-free nucleic acid extraction kits (cfPure) and matched mutational quantification control plasma reference materials used in liquid biopsy workflows such as cell-free DNA isolation and downstream molecular analysis.
- Reference and Control Standards (FDA-approved tissue arrays, characterized tissues, HCR verified tissue, reference DNA/RNA/protein, plasma) Reference tissues, reference DNA/RNA/protein, plasma reference materials, FDA-approved tissue arrays, NGS- and 10x Visium-characterized tissues, and HCR verified tissues used as controls and benchmarks in molecular diagnostic and research assays, including clinical trial and diagnostic test development.
- Spatial Multiomics Services (10x Visium HD, 10x Xenium Prime 5K, NanoString GeoMx DSP) End-to-end fee-for-service spatial biology offerings combining client tissue samples with 10x Visium HD whole-transcriptome analysis at 2µm resolution, 10x Xenium Prime 5K single-cell imaging of up to 5,000 genes, and NanoString GeoMx DSP multiplexed protein/RNA profiling, delivered by BioChain as a certified service provider.
- Custom Histology Services (tissue sectioning, microarray construction, whole slide imaging, FFPE cell line blocks) Custom histology services covering tissue sectioning and tissue microarray construction, whole slide imaging, and preparation of FFPE cell line and cell culture blocks for research and assay development customers.
- OEM and Custom Manufacturing Services (ISO 9001:2015) ISO 9001:2015 certified OEM and custom manufacturing services for bulk reagent supply, custom extraction and purification, biospecimen procurement, and targeted gene expression profiling for partner manufacturers and research customers.
Quantifiable outcome
- 10x Genomics and NanoString certified spatial biology services for whole transcriptome and targeted spatial profiling
- +3 more outcomes
Companies that use Biochain
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles4 records
Biochain technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature8 records
Biochain partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Ambergen, Inc.coreBioChain co-hosts a joint webinar with Ambergen, Inc. titled 'Unlocking the Full Potential of Biospecimens for Multiomic and Spatial Analyses' scheduled for February 24, 2026. The collaboration brings together BioChain's biospecimen expertise with Ambergen's bioinformatics and spatial multiomic imaging capabilities. Featured presenters include Nisshanthini Durairaju (BioChain), Leonardo Garcia Dettori (Ambergen), and John Gillespie, President and CEO of Ambergen. The webinar focuses on integrated workflows combining proteomic, lipidomic, and transcriptomic imaging for multiomic research applications.
- 10x GenomicscoreBioChain is a certified provider for 10x Genomics spatial biology platforms, offering 10x Visium HD and 10x Xenium Prime 5K characterized tissues and spatial multiomics services. BioChain provides pre-validated, spatially characterized human tissue sections compatible with 10x Genomics Visium HD and Xenium workflows, enabling whole transcriptome and targeted gene expression spatial profiling.
- NanoString TechnologiescoreBioChain is NanoString certified, offering NanoString GeoMx DSP characterized tissues and spatial profiling services. The partnership enables customers to access NanoString's digital spatial profiling technology with BioChain's characterized tissue products for multiplexed protein and RNA analysis in tissue sections.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Biochain competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Charles River provides research models, biospecimens, discovery, and safety assessment services to pharma and biotech. Its Research Models & Services and biospecimen supply overlap with BioChain's IRB-approved biospecimen procurement and custom lab services for translational and clinical research.
- Abcam: Abcam is a leading research-reagent company specializing in antibodies and protein research tools, serving pharma, biotech, and academic markets globally. It is comparable to BioChain as a catalog reagent and reference-materials provider, though with a primary focus on antibodies rather than biospecimens and spatial workflows.
- MilliporeSigma (Merck KGaA Life Science): MilliporeSigma is the life-science arm of Merck KGaA, offering a vast portfolio of reagents, kits, instruments, and reference standards used in molecular biology, genomics, and bioprocessing. It competes with BioChain across extraction kits, sample prep consumables, and reference materials, with a much larger global scale and instrument footprint.
- Bio-Techne: Bio-Techne is a large, diversified life-science tools provider offering proteins, antibodies, reagents, and biospecimens across research and diagnostics. It is comparable to BioChain as a competing supplier of research-grade reagents and biospecimens to pharma/biotech and academic customers, though with a far broader and more clinical-diagnostic-anchored portfolio.
Emerging players
- Proteintech Group: Proteintech is a rapidly growing antibody and protein reagent manufacturer serving academic and pharma researchers worldwide. It is comparable to BioChain as a catalog reagent supplier targeting publication-driven researchers, though with a narrower focus on antibodies and proteins rather than biospecimens and spatial workflows.
- Akoya Biosciences: Akoya is a spatial biology specialist offering the PhenoCycler and PhenoImager platforms for multiplex tissue imaging. It overlaps with BioChain's spatial multiomics service offering as a competing spatial technology platform with which BioChain could partner or against which it positions its 10x/NanoString certified services.
Direct peers
- OriGene Technologies: OriGene is a direct competitor supplying cDNA clones, antibodies, FFPE and frozen tissue arrays, RNA/DNA extracts, and molecular biology reagents to academic and pharma researchers. Its catalog overlaps closely with BioChain's biospecimens, extraction kits, and reference standards for spatial and molecular applications.
- Cell Signaling Technology: Cell Signaling Technology (CST) is a research-reagent specialist producing antibodies, ELISA kits, and validation-grade protein tools for signaling pathway and biomarker research. It overlaps with BioChain's reference protein and antibody-adjacent reagent offerings and similarly serves pharma R&D and academic customers seeking publication-grade data.
- Discovery Life Sciences: Discovery Life Sciences is a biospecimen procurement and analytical services provider offering human tissue, biofluids, and custom lab services to translational and clinical research customers. It is one of the closest direct peers to BioChain's core biospecimen and custom extraction/purification business, with comparable IRB-governed sourcing and pharma/academic customer base.
Regional players
- AMS Biotechnology (AMSBIO): AMSBIO is a UK-based supplier of life-science research reagents, biospecimens, primary cells, and molecular biology kits primarily serving European and APAC academic/biotech markets. It is comparable to BioChain as a competing catalog biospecimen and reagent provider, though operating through a different geographic footprint and distributor-led channel.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Biochain social profiles
Digital presenceBiochain financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biochain leadership team
Management profileNumber of profiles
Profiles2 records
Biochain funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biochain M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biochain
What does Biochain do?
BioChain supplies human biospecimens (FFPE and frozen tissue, DNA, RNA, protein, matched pair samples), automated nucleic acid extraction instruments (AnaPrep 12 Dx and AnaPrep 48), magnetic bead-based extraction kits (xTractPure), reference and control standards (FDA-approved tissue arrays, characterized tissues), and fee-for-service spatial multiomics and histology services to pharmaceutical, biotechnology, academic, and government research customers.
Is Biochain a public or private company?
Biochain is a private company. It is classified as unknown and is currently operating.
When was Biochain founded?
Biochain was founded in 1994. It employs 251 to 500 people.
Where is Biochain based?
Biochain is headquartered in Newark, United States, in the North America region.
How does Biochain make money?
Five revenue lines are on record. Biospecimen Sales are the primary driver. The others are automated Instruments, extraction and Purification Kits, custom Services and reference and Control Standards.
Who are Biochain's main competitors?
Broad incumbents on record are Charles River Laboratories, Abcam, MilliporeSigma (Merck KGaA Life Science) and Bio-Techne. Emerging players are Proteintech Group and Akoya Biosciences. Direct peers are OriGene Technologies, Cell Signaling Technology and Discovery Life Sciences. AMS Biotechnology (AMSBIO) is listed as a regional player.
Does Biochain have an API?
No public API is recorded for Biochain.
What industry is Biochain in?
Biochain's product category is Life Science Research Products. Its primary akta.pro industry code is HLAAALAM, Sample Collection, Stabilization & Pre-Analytics (biobanking, transport media, extraction kits), with a secondary code of HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays). Its NAICS code is 325413 and its SIC code is 8731.